TAK-660-403

TAK-660-403

Free
Click to generate a QR code for easy access to the app on the App Store
Rating summary

About TAK

  • Released
  • Updated
  • iOS Version
  • Age Rating
  • Size
  • Devices
  • Languages

Developer of TAK

TAK-660-403 screenshot #1 for iPhone
TAK-660-403 screenshot #2 for iPhone
TAK-660-403 screenshot #3 for iPhone
TAK-660-403 screenshot #4 for iPhone
iphone
ipad
🗣❌ unsupported
Your locale
🖼️Download
Icons↘︎
An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)
Show less

What's New in TAK

1.2

January 9, 2024

- Bug fixes for iOS 17

Alternatives to TAK

More Applications by ERT, INC

TAK FAQ

Does TAK work on iPads?

Yes, TAK is iPad-friendly.

Who created the app?

TAK was released by ERT, INC.

What minimum version of iOS does TAK need?

The minimum required iOS version for the app to work is 10.0 or higher.

What do users think of the TAK app?

The TAK app doesn’t have enough ratings and reviews yet.

What genre is the TAK app?

The App Category Of Tak Is Medical.

What is the latest version of TAK?

The latest TAK version released is 1.2.

What is the update date for TAK?

The latest TAK update was released on December 2, 2024.

When was the app initially released?

The TAK app originally came out on February 5, 2023.

What content advisory rating does TAK have?

TAK doesn’t contain potentially objectionable material and is rated ERT, INC.

What are the languages supported by the TAK app?

Currently, TAK supports English.

Is TAK included in the roster of games on Apple Arcade?

No, TAK is not on Apple Arcade.

Does TAK support in-app purchases?

No, TAK does not support in-app purchases.

Is TAK designed for Apple Vision Pro integration?

Sorry, TAK is not designed for integration with Apple Vision Pro.

Are there commercial ads in TAK?

No, there are no commercial ads in TAK.